Site of cancer
|
ICD-8
|
Obs
|
Exp6-152
|
SRR
|
(95% CI)
|
Lip | 140 | 0 | 0.7 | 0 | — |
Tongue | 141 | 0 | 0.9 | 0 | — |
Salivary gland | 142 | 1 | 0.5 | 200 | (5 to 1114) |
Mouth | 143–5 | 3 | 1.2 | 250 | (52 to 731) |
Pharynx | 146–9 | 2 | 1.7 | 118 | (14 to 425) |
Oesophagus | 150 | 7 | 6.3 | 111 | (45 to 229) |
Stomach | 151 | 24 | 18.7 | 128 | (82 to 191) |
Small intestine | 152 | 0 | 0.5 | 0 | — |
Large intestine | 153 | 18 | 16.8 | 107 | (63 to 169) |
Rectum | 154 | 17 | 13.6 | 125 | (73 to 200) |
Liver | 155 | 4 | 1.5 | 267 | (73 to 683) |
Gall bladder | 156 | 1 | 1.3 | 77 | (2 to 429) |
Pancreas | 157 | 9 | 7.7 | 117 | (53 to 222) |
Peritoneum and other digestive | 158–9 | 1 | 0.7 | 143 | (4 to 796) |
Nose and sinuses | 160 | 0 | 0.6 | 0 | — |
Larynx | 161 | 3 | 4.1 | 73 | (15 to 214) |
Lung and bronchus | 162–3 | 65 | 74.4 | 87 | (67 to 111) |
Bone | 170 | 1 | 0.4 | 250 | (6 to 1393) |
Connective tissue | 171 | 0 | 1.0 | 0 | — |
Malignant melanoma | 172 | 0 | 1.8 | 0 | — |
Breast | 174 | 1 | 0.5 | 200 | (5 to 1114) |
Prostate | 185 | 12(6-150) | 23.3 | 52 | (27 to 90) |
Testis | 186 | 0 | 1.0 | 0 | — |
Other genital | 187 | 2 | 0.8 | 250 | (30 to 903) |
Bladder | 188 | 19 | 17.7 | 107 | (65 to 168) |
Other urinary | 189 | 9 | 4.9 | 184 | (84 to 349) |
Eye | 190 | 0 | 0.4 | 0 | — |
Brain | 191–2 | 4 | 3.5 | 114 | (31 to 293) |
Thyroid | 193 | 0 | 0.5 | 0 | — |
Other endocrine | 194 | 0 | 0.2 | 0 | — |
Secondary and other | 195–9 | 19 | 12.1 | 157 | (95 to 245) |
Hodgkin's disease | 201 | 0 | 1.2 | 0 | — |
Lymphosarcoma | 200,202 | 2 | 5.1 | 39 | (5 to 142) |
Multiple myeloma | 203 | 4 | 2.8 | 143 | (39 to 366) |
Leukaemia | 204–7 | 5 | 5.1 | 98 | (32 to 229) |
All cancers6-153
| 140–207 | 234 | 233.6 | 100 | (88 to 114) |